Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Vaccines

Free Subscription Articles published in J Virol Retrieve available abstracts of 102 articles: HTML format

Single Articles

April 2008
1. BANSAL A , Jackson B, West K, Wang S, et al
   Multifunctional T cell characteristics induced by a polyvalent DNA prime/protein boost HIV-1 vaccine regimen given to healthy adults are dependant upon the route and dose of administration.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. KAUFMAN DR , Goudsmit J, Holterman L, Ewald BA, et al
   Differential Antigen Requirements for Protection Against Systemic and Intranasal Vaccinia Virus Challenges in Mice.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. LIN YC , Li J, Irwin CR, Jenkins H, et al
   Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. NELSON GE , Wagenaar TR, Moss B
   A Conserved Sequence Within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex is Important for Interaction with the A28 Subunit and Infectivity.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. LEE E , Lobigs M
   E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impedes virus spread and attenuates virulence.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
6. LIU J , Kjeken R, Mathiesen I, Barouch DH, et al
   Recruitment of Antigen-Presenting Cells to the Site of Inoculation and Augmentation of HIV-1 DNA Vaccine Immunogenicity by In Vivo Electroporation.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. WAGENAAR TR , Ojeda S, Moss B
   The vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. GAO Q , Park MS, Palese P
   Expression of transgenes from newcastle disease virus with a segmented genome.
   J Virol. 2008;82:2692-8.
   PubMed     Related articles    Abstract available
   
   
   
9. CASTILOW EM , Olson MR, Meyerholz DK, Varga SM, et al
   Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.
   J Virol. 2008;82:2196-207.
   PubMed     Related articles    Abstract available
   
   
   February 2008
10. GIRGIS NM , Dehaven BC, Fan X, Viner KM, et al
    Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. DOMI A , Weisberg AS, Moss B
    Vaccinia Virus E2L Null Mutants Exhibit a Major Reduction in Extracellular Virion Formation and Virus Spread.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. MANSFIELD K , Lang SM, Gaudin MC, Sanford HB, et al
    VACCINE PROTECTION BY LIVE ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS IN THE ABSENCE OF HIGH TITER ANTIBODY RESPONSES AND HIGH FREQUENCY CELLULAR IMMUNE RESPONSES MEASUREABLE IN THE PERIPHERY.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. WU WL , Chen Y, Wang P, Song W, et al
    Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.
    J Virol. 2008;82:1798-807.
    PubMed     Related articles    Abstract available
    
    
    
14. ARITA M , Ami Y, Wakita T, Shimizu H, et al
    Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model.
    J Virol. 2008;82:1787-97.
    PubMed     Related articles    Abstract available
    
    
    January 2008
15. BENHNIA MR , McCausland MM, Su HP, Singh K, et al
    Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. TAGMYER TL , Craigo JK, Cook SJ, Even DL, et al
    ENVELOPE DETERMINANTS OF EIAV VACCINE PROTECTION AND THE EFFECTS OF SEQUENCE VARIATION ON IMMUNE RECOGNITION.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. SADAGOPAL S , Amara RR, Kannanganat S, Sharma S, et al
    Expansion and exhaustion of T cell responses during mutational escape from long-term viral control in two DNA/MVA vaccinated and SHIV-89.6P challenged macaques.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. BALAMURUGAN A , Lewis MJ, Kitchen CM, Robertson MN, et al
    Primary HIV-1 Infection During HIV-1 Gag Vaccination.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. BIRD BH , Albarino CG, Hartman AL, Erickson BR, et al
    Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge and allows for differential identification of infected and vaccinated animals.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. BERHANU A , Wilson RL, Kirkwood-Watts DL, King DS, et al
    Vaccination of BALB/c Mice with Escherichia coli-expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. MOOIJ P , Balla-Jhagjhoorsingh SS, Koopman G, Beenhakker N, et al
    Differential CD4+ versus CD8+ T-cell responses elicited by different Poxvirus-based HIV-1 vaccine candidates provide comparable efficacy in primates.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. LOPES L , Dewannieux M, Gileadi U, Bailey R, et al
    Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.
    J Virol. 2008;82:86-95.
    PubMed     Related articles    Abstract available
    
    
    December 2007
23. WATANABE T , Watanabe S, Kim JH, Hatta M, et al
    A novel approach to the development of effective H5N1 influenza A virus vaccines: the use of M2 cytoplasmic tail mutants.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. PERDIGUERO B , Del Mar Lorenzo M, Blasco R
    VACCINIA VIRUS A34 GLYCOPROTEIN DETERMINES THE PROTEIN COMPOSITION OF THE EXTRACELLULAR VIRUS ENVELOPE.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. YU JR , Kim S, Lee JB, Chang J, et al
    Single Intranasal Immunization with Recombinant Adenovirus-Based Vaccine Induces Protective Immunity against Respiratory Syncytial Virus Infection.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. EARLEY AK , Chan WM, Ward BM
    The Vaccinia Virus B5 Protein Requires A34 for Efficient Intracellular Trafficking from the ER to the Site of Wrapping and Incorporation into Progeny Virions.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. RUAT C , Caillet C, Bidaut A, Simon J, et al
    Vaccination of macaques with adjuvanted formalin-inactivated influenza A (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. HE CQ , Ding NZ, Han GZ, Liu W, et al
    Natural recombination between Newcastle disease virus vaccine strains and circulating viruses.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. SANTIN AD , Bellone S, Palmieri M, Zanolini A, et al
    Human Papillomavirus 16/18 E7-Pulsed Dendritic Cell Vaccination in Stage IB-IIA Cervical Cancer Patients; A Phase I Escalating Dose Trial.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. HARKER J , Bukreyev A, Collins PL, Wang B, et al
    Virally delivered cytokines alter the immune response to future lung infections.
    J Virol. 2007;81:13105-11.
    PubMed     Related articles    Abstract available
    
    
    
31. MOK H , Lee S, Utley TJ, Shepherd BE, et al
    Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.
    J Virol. 2007;81:13710-22.
    PubMed     Related articles    Abstract available
    
    
    November 2007
32. MURAKAMI S , Horimoto T, Yamada S, Kakugawa S, et al
    Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: its Application for H5N1 Vaccine Production.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. ELLIOTT SL , Suhrbier A, Miles JJ, Lawrence G, et al
    A Phase I trial of a CD8+ T Cell Peptide Epitope-based Vaccine for Infectious Mononucleosis.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. HOOPER JW , Ferro AM, Wahl-Jensen V
    Immune Serum Produced by DNA Vaccination Protects Hamsters Against Lethal Respiratory Challenge with Andes Virus.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. QUAN FS , Compans RW, Nguyen HH, Kang SM, et al
    Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. CHING LK , Vlachogiannis G, Bosch KA, Stamatatos L, et al
    The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous HIV-1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. LACASSE P , Denis J, Lapointe R, Leclerc D, et al
    Novel plant virus-based vaccine induces protective CTL-mediated antiviral immunity through dendritic cell maturation.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. SCHOENLY KA , Weiner DB
    HIV-1 Vaccine Development: Recent Advances in the CTL Platform "Spotty Business"
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. OLIPHANT T , Nybakken GE, Austin SK, Xu Q, et al
    Induction of epitope-specific neutralizing antibodies against West Nile virus.
    J Virol. 2007;81:11828-39.
    PubMed     Related articles    Abstract available
    
    
    
40. GAMBHIRA R , Jagu S, Karanam B, Gravitt PE, et al
    Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
    J Virol. 2007;81:11585-92.
    PubMed     Related articles    Abstract available
    
    
    
41. KIM LM , King DJ, Curry PE, Suarez DL, et al
    Phylogenetic diversity among low-virulence newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to those of poultry-origin isolates.
    J Virol. 2007;81:12641-53.
    PubMed     Related articles    Abstract available
    
    
    October 2007
42. SEN P , Charini WA, Subbramanian RA, Manuel ER, et al
    Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. DAVIES DH , Wyatt LS, Newman FK, Earl PL, et al
    Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine, Modified Vaccinia Virus Ankara (MVA) is Comparable to Dryvax(R).
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. DOMINGO-GIL E , Perez-Jimenez E, Ventoso I, Najera JL, et al
    Expression of the E3L gene of vaccinia virus in transgenic mice decreases the host resistance to vaccinia virus and Leishmania major infection.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. ZHANG P , Jacobs BL, Samuel CE
    Loss of Protein Kinase PKR Expression in Human HeLa Cells Complements the Vaccinia Virus E3L Deletion Mutant Phenotype by Restoration of Viral Protein Synthesis.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. LI Y , Cleveland B, Klots I, Travis B, et al
    Removal of a single N-linked glycan in HIV-1 gp120 results in enhanced ability to induce neutralizing antibody responses.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. DEPLA E , Van der Aa A, Livingston BD, Crimi C, et al
    Rational design of a multi-epitope vaccine encoding T-lymphocyte epitopes for treatment of chronic HBV infections.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. COOPER D , Wright KJ, Calderon PC, Guo M, et al
    Attenuation of Recombinant Vesicular Stomatitis Virus HIV-1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. LEEN AM , Christin A, Khalil M, Weiss H, et al
    Identification of hexon-specific CD4 and CD8 T cell epitopes for vaccine and immunotherapy.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. DENG L , Dai P, Ciro A, Smee DF, et al
    Identification of novel antipoxviral agents: Mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. CICIN-SAIN L , Bubic I, Schnee M, Ruzsics Z, et al
    TARGETED DELETION OF REGIONS RICH IN IMMUNE EVASIVE GENES FROM THE CYTOMEGALOVIRUS GENOME AS NOVEL VACCINE STRATEGY.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. LJUNGBERG K , Whitmore AC, Fluet ME, Moran TP, et al
    Increased immunogenicity of a DNA-launched VEE-based replicon DNA vaccine.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. WU TC , Wang YF, Lee YP, Wang JR, et al
    Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice.
    J Virol. 2007;81:10310-5.
    PubMed     Related articles    Abstract available
    
    
    September 2007
54. STAHL-HENNIG C , Kuate S, Franz M, Suh YS, et al
    ATRAUMATIC ORAL SPRAY IMMUNIZATION WITH REPLICATION-DEFICIENT VIRAL VECTOR VACCINES.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. SILIN D , Lyubomska O, Ludlow M, Duprex WP, et al
    Development of a challenge-protective vaccine concept by modifying the viral RNA-dependent RNA polymerase of canine distemper virus.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. PEUT V , Kent SJ
    Utility of HIV-1 Envelope as a T Cell Immunogen.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. PARRISH S , Moss B
    Characterization of a Second Vaccinia Virus mRNA Decapping Enzyme Conserved in Poxviruses.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. WAIBLER Z , Anzaghe M, Ludwig H, Akira S, et al
    Modified vaccinia virus Ankara induces Toll-like receptor independent type I interferon responses.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. VANPOUILLE C , Biancotto A, Lisco A, Brichacek B, et al
    Interactions between HIV-1 and vaccinia virus in human lymphoid tissue ex vivo.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. THEBEAU LG , Vagvala SP, Wong YM, Morrison LA, et al
    B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. ARITA M , Nagata N, Iwata N, Ami Y, et al
    An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.
    J Virol. 2007;81:9386-95.
    PubMed     Related articles    Abstract available
    
    
    August 2007
62. TSUKAMOTO T , Yuasa M, Yamamoto H, Kawada M, et al
    Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus mac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. DINAPOLI JM , Yang L, Suguitan A Jr, Elankumaran S, et al
    Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. LIN J , Zhi Y, Mays L, Wilson JM, et al
    Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T cell responses in mice.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. BASKIN CR , Bielefeldt-Ohmann H, Garcia-Sastre A, Tumpey TM, et al
    Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. CHEN L , Ewing D, Subramanian H, Block K, et al
    A heterologous DNA prime-VRP (VEE Replicon Particle) boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. GASTEIGER G , Kastenmuller W, Ljapoci R, Sutter G, et al
    Crosspriming of Cytotoxic T-cells Dictates Antigen Requisites for MVA Vector Vaccines.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. ADAMS MM , Rice AD, Moyer RW
    RABBITPOX AND VACCINIA VIRUS INFECTION OF RABBITS AS A MODEL FOR HUMAN SMALLPOX.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. KANNANGANAT S , Ibegbu C, Chennareddi L, Robinson HL, et al
    Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.
    J Virol. 2007;81:8468-76.
    PubMed     Related articles    Abstract available
    
    
    
70. LEMON K , Rima BK, McQuaid S, Allen IV, et al
    The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.
    J Virol. 2007;81:8293-302.
    PubMed     Related articles    Abstract available
    
    
    
71. DAS AT , Klaver B, Harwig A, Vink M, et al
    Construction of a Doxycycline-Dependent Simian Immunodeficiency Virus Reveals a Non-Transcriptional Function of Tat in Viral Replication.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
72. WHITE LJ , Parsons MM, Whitmore AC, Williams BM, et al
    An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. MENNE S , Tennant BC, Gerin JL, Cote PJ, et al
    Chemo-Immunotherapy of Chronic Hepatitis B Virus Infection in, the Woodchuck Model Breaks Immunologic Tolerance and Restores, T cell Responses to PreS- and S-Regions of the Viral Envelope Protein.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. BUONAGURO L , Tornesello ML, Buonaguro FM
    HIV-1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. REYES DEL VALLE J , Devaux P, Hodge G, Wegner NJ, et al
    A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles challenge.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. ABDEL-MOTAL UM , Guay HM, Wigglesworth K, Welsh RM, et al
    Increased immunogenicity of influenza virus vaccine by anti-Gal mediated targeting to antigen presenting cells.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. WANG X , Uto T, Akagi T, Akashi M, et al
    Induction of Potent CD8+ T-Cell Responses by Novel Biodegradable Nanoparticles Carrying Human Immunodeficiency Virus Type 1 gp120.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. BOXUS M , Tignon M, Roels S, Toussaint JF, et al
    DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.
    J Virol. 2007;81:6879-89.
    PubMed     Related articles    Abstract available
    
    
    
79. TAHARA M , Takeda M, Yanagi Y
    Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion.
    J Virol. 2007;81:6827-36.
    PubMed     Related articles    Abstract available
    
    
    June 2007
80. SONG H , Nieto GR, Perez DR
    A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. IM EJ , Saubi N, Virgili G, Sander C, et al
    Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of HIV-1 through Breastfeeding.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. CHEN Z , Earl P, Americo J, Damon I, et al
    Characterization of chimpanzee/human monoclonal antibodies to the vaccinia A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia mouse protection model.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. VERMEER PD , McHugh J, Rokhlina T, Vermeer DW, et al
    Vaccinia Virus Entry, Exit, and Interaction with Differentiated Human Airway Epithelia.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. TOWNSLEY AC , Moss B
    Two Distinct Low pH Steps Promote Entry of Vaccinia Virus.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. PERERA LP , Waldmann TA, Mosca JD, Baldwin N, et al
    Development of Smallpox Vaccine Candidates with Integrated IL-15 that Demonstrate Superior Immunogenicity, Efficacy and Safety in Mice.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. BUKREYEV A , Rollin PE, Tate MK, Yang L, et al
    Successful topical respiratory tract immunization of primates against Ebola virus.
    J Virol. 2007;81:6379-88.
    PubMed     Related articles    Abstract available
    
    
    May 2007
87. ROLLAND M , Jensen MA, Nickle DC, Yan J, et al
    Reconstruction and function of Ancestral Center-Of-Tree (COT) HIV-I Proteins.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. ALDAZ-CARROLL L , Xiao Y, Whitbeck JC, Ponce de Leon M, et al
    Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. QUAKKELAAR ED , van Alphen FP, Boeser-Nunnink BD, van Nuenen AC, et al
    Susceptibility of Recently Transmitted Subtype B HIV-1 Variants to Broadly Neutralizing Antibodies.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
90. HONEYCHURCH KM , Yang G, Jordan R, Hruby DE, et al
    The Vaccinia Virus F13L YPPL Motif is Required for the Efficient Release of Extracellular Enveloped Virus.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
91. FABER M , Faber ML, Li J, Preuss MA, et al
    Dominance of a non-pathogenic over a pathogenic glycoprotein gene in rabies virus.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
92. MCCOY K , Tatsis N, Korioth-Schmitz B, Lasaro MO, et al
    The effect of pre-existing immunity to antigens of adenovirus of the human serotype 5 on immune responses of nonhuman primates to vaccine regimens based on human or chimpanzee-derived adenovirus vectors.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. MILUSH JM , Stefano-Cole K, Schmidt K, Durudas A, et al
    Mucosal Innate Immune Response Associated With A Timely Humoral Immune Response And Slower Disease Progression Following Oral Transmission Of SIV In Rhesus Macaques.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. WAGENAAR TR , Moss B
    Association of Vaccinia Virus Fusion Regulatory Proteins with the Multicomponent Entry/Fusion Complex.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. ZHANG X , Cassis-Ghavami F, Eller M, Currier J, et al
    Direct Comparison of Antigen Production and Induction of Apoptosis by Canarypoxvirus and Modified Vaccinia Ankara (MVA) HIV Vaccine Vectors.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. SMILEY KL , McNeal MM, Basu M, Choi AH, et al
    Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
    J Virol. 2007;81:3740-8.
    PubMed     Related articles    Abstract available
    
    
    March 2007
97. BRANDSMA JL , Shylankevich M, Su Y, Roberts A, et al
    Vesicular stomatitis virus (VSV)-based therapeutic vaccination targeted to the E1, E2, E6 and E7 proteins of cottontail rabbit papillomavirus (CRPV).
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. VELU V , Kannanganat S, Ibegbu C, Chennareddi L, et al
    Elevated Expression of the Inhibitory Receptor Programmed Death-1 on Simian Immunodeficiency Virus-Specific CD8 T Cells During Chronic Infection but not Following Vaccination.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. PENG Y , Lin FC, Verardi PH, Jones LA, et al
    Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro.
    J Virol. 2007;81:2187-95.
    PubMed     Related articles    Abstract available
    
    
    
100. BOTTEN J , Whitton JL, Barrowman P, Sidney J, et al
     HLA-A2-restricted protection against lethal lymphocytic choriomeningitis.
     J Virol. 2007;81:2307-17.
     PubMed     Related articles    Abstract available
     
     
     February 2007
101. VON GEGERFELT AS , Rosati M, Alicea C, Valentin A, et al
     Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization.
     J Virol. 2007;81:1972-9.
     PubMed     Related articles    Abstract available
     
     
     January 2007
102. LAW M , Cardoso RM, Wilson IA, Burton DR, et al
     Antigenic and immunogenic study of MPER-grafted gp120 antigens by DNA prime-protein boost immunization strategy.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: